Hanping Wang

2.6k citations
116 papers · 1.9k · 1 hit paper · h-index 22

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • COVID-19 and healthcare impacts
    • Lung Cancer Research Studies

Papers in

Hanping Wang

108 papers receiving 1.8k citations

Hanping Wang's Hit Papers

Risk of COVID-19 for patients with cancer 2020 · 350 citations
3500+2+4Years since publication100200300

Peers

Hanping Wang
Comparison fields: 5 of 114
  • Oncology 769
  • General Dentistry 6
  • Pulmonary and Respiratory Medicine 318
  • Hepatology 50
  • Periodontics 34
Replace Giuseppe Ingravallo with:
Giuseppe Ingravallo Italy
James J. Farrell United States
Ying‐Huang Tsai Taiwan
Alessandro Vanoli Italy
Jing Chen China
Gerardo Cazzato Italy
Shunsuke Yamamoto Japan
Atsuhiro Masuda Japan
Hyun Jung Lee South Korea
Hua Jiang China
Hanping Wang relative to Giuseppe Ingravallo Italy Giuseppe Ingravallo's profile →
Citations per field
00.5×2×3.1×
Giuseppe Ingravallo · 1×
Citations per year

Countries citing papers authored by Hanping Wang

Since Specialization
Citations

This map shows the geographic impact of Hanping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanping Wang more than expected).

Fields of papers citing papers by Hanping Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanping Wang. The network helps show where Hanping Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Hanping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hanping Wang Line = papers co-authored together Hanping Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Risk of COVID-19 for patients with cancer
Hit paper breakdown →
2020350
2 201978
3 202075
4 202164
5 202460
6 201955
7 202150
8 202248
9
Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer.
201136
10 202035
11 201834
12 201833
13 202433
14 202032
15 202432
16 201630
17 201729
18 202328
19 201925
20 201623

About Hanping Wang

Hanping Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Rheumatology, Ecology, Evolution, Behavior and Systematics and Cardiology and Cardiovascular Medicine, having authored 116 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (50 papers), Lung Cancer Treatments and Mutations (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Lung Cancer Research Studies (4 papers), Plant Ecology and Taxonomy Studies (4 papers), IgG4-Related and Inflammatory Diseases (4 papers), Plant Diversity and Evolution (4 papers) and Gut microbiota and health (4 papers). The work is most often cited by research in Oncology (769 citations), General Dentistry (6 citations), Pulmonary and Respiratory Medicine (318 citations), Hepatology (50 citations) and Periodontics (34 citations). Hanping Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Li Zhang, Xiaoyan Si, Xiaotong Zhang, Mengzhao Wang, Lian Duan, Xiaoxiao Guo, Jiaxin Zhou, Peng Song, Haitao Zhao and Xiaoxia Cui. Their work appears in journals such as Thoracic Cancer, Lung Cancer, Frontiers in Oncology, BMC Medicine and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact